Krystal Biotech, Inc.
KRYS- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001711279
In the last 90 days, Krystal Biotech, Inc. insiders filed 0 open-market purchases and 3 sales; 422 institutions reported holding it in 13F filings for Q2 2026, worth $11.1B in total; no superinvestor holds it.
13F holders, Q4 2022
Institutional positions in Krystal Biotech, Inc. as of Dec 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 154
- +8 vs. Q3 2022
- Shares held
- 20.9M
- +147.3K (+0.7%) vs. Q3 2022
- Total value
- $1.66B
- +$208.7M (+14.4%) vs. Q3 2022
- New holders
- 18
- 62 more added
- Sold out
- 10
- 50 more reduced
2 institutions that held it in Q3 2022 haven't filed for Q4 2022 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q3 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting KRYS on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 422 | $11.1B |
| Q1 2026 | 368 | $7.32B |
| Q4 2025 | 334 | $7.01B |
| Q3 2025 | 284 | $4.94B |
| Q2 2025 | 275 | $3.80B |
| Q1 2025 | 299 | $4.98B |
| Q4 2024 | 264 | $4.35B |
| Q3 2024 | 283 | $5.15B |
| Q2 2024 | 245 | $5.24B |
| Q1 2024 | 234 | $4.49B |
| Q4 2023 | 194 | $3.03B |
| Q3 2023 | 188 | $2.76B |
| Q2 2023 | 183 | $2.71B |
| Q1 2023 | 160 | $1.68B |
| Q4 2022 | 154 | $1.66B |
| Q3 2022 | 148 | $1.45B |
| Q2 2022 | 137 | $1.36B |
| Q1 2022 | 135 | $1.37B |
| Q4 2021 | 140 | $1.35B |
| Q3 2021 | 113 | $850.7M |
| Q2 2021 | 113 | $1.12B |
| Q1 2021 | 113 | $1.27B |
Institutions, Q4 2022
Shares, value and share of portfolio for each institution holding Krystal Biotech, Inc.; share changes are against Q3 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| State of New Jersey Common Pension Fund D | 29,901 | $2.37M | 0.01% | −3,561−10.6% | Reduced |
| DekaBank Deutsche Girozentrale | 30,300 | $2.38M | 0.01% | 00.0% | Unchanged |
| Rhumbline Advisers | 31,834 | $2.52M | 0.00% | +711+2.3% | Added |
| EAM Investors, LLC | 33,245 | $2.63M | 0.55% | −194−0.6% | Reduced |
| Barclays PLC | 36,348 | $2.88M | 0.00% | +3,217+9.7% | Added |
| CWM, LLC | 37,130 | $2.94M | 0.02% | −6,254−14.4% | Reduced |
| SG Americas Securities, LLC | 38,774 | $3.07M | 0.05% | +36,434+1,557.0% | Added |
| UBS Group AG | 42,623 | $3.38M | 0.00% | +42,459+25,889.6% | Added |
| Swiss National Bank | 43,400 | $3.44M | 0.00% | +800+1.9% | Added |
| International Biotechnology Trust PLC | 45,000 | $3.56M | 1.10% | 00.0% | Unchanged |
| Hennion & Walsh Asset Management, Inc. | 45,203 | $3.58M | 0.22% | +4,547+11.2% | Added |
| Citadel Advisors LLC | 52,676 | $4.17M | 0.00% | +43,938+502.8% | Added |
| Monarch Partners Asset Management LLC | 53,905 | $4.27M | 1.26% | +7,411+15.9% | Added |
| Nuveen Asset Management, LLC | 57,412 | $4.55M | 0.00% | −27,913−32.7% | Reduced |
| Silverarc Capital Management, LLC | 58,535 | $4.64M | 1.60% | +1,890+3.3% | Added |
| Rafferty Asset Management, LLC | 61,625 | $4.88M | 0.04% | +9,369+17.9% | Added |
| Voya Investment Management LLC | 62,609 | $4.96M | 0.01% | −1,577−2.5% | Reduced |
| Morgan Stanley | 66,051 | $5.23M | 0.00% | +18,738+39.6% | Added |
| Bank of America Corp | 68,043 | $5.39M | 0.00% | +26,679+64.5% | Added |
| Verition Fund Management LLC | 80,561 | $6.38M | 0.12% | +12,909+19.1% | Added |
| Bank of New York Mellon Corp | 82,096 | $6.50M | 0.00% | −2,696−3.2% | Reduced |
| Rubric Capital Management LP | 92,609 | $7.34M | 0.32% | 00.0% | Unchanged |
| Handelsbanken Fonder AB | 105,200 | $8.33M | 0.05% | +300+0.3% | Added |
| ExodusPoint Capital Management, LP | 105,761 | $8.38M | 0.13% | +40,975+63.2% | Added |
| S Squared Technology, LLC | 108,215 | $8.57M | 5.80% | 00.0% | Unchanged |
| Integral Health Asset Management, LLC | 115,000 | $9.11M | 2.05% | +25,000+27.8% | Added |
| Goldman Sachs Group Inc | 147,601 | $11.7M | 0.00% | +5,216+3.7% | Added |
| Charles Schwab Investment Management Inc | 160,615 | $12.7M | 0.00% | +4,344+2.8% | Added |
| Deerfield Management Company, L.P. (Series C) | 175,000 | $13.9M | 0.29% | 00.0% | Unchanged |
| Soleus Capital Management, L.P. | 188,217 | $14.9M | 2.14% | −19,115−9.2% | Reduced |
| Northern Trust Corp | 201,288 | $15.9M | 0.00% | −950−0.5% | Reduced |
| C WorldWide Group Holding A/S | 225,809 | $17.9M | 0.24% | 00.0% | Unchanged |
| JPMorgan Chase & Co | 237,937 | $18.8M | 0.00% | −4,756−2.0% | Reduced |
| Nicholas Investment Partners, LP | 267,089 | $21.2M | 1.85% | +45,063+20.3% | Added |
| Skandinaviska Enskilda Banken AB (publ) | 287,541 | $22.8M | 0.17% | −10,069−3.4% | Reduced |
| Baker Bros. Advisors LP | 302,716 | $24.0M | 0.14% | −119,469−28.3% | Reduced |
| Victory Capital Management Inc | 339,331 | $26.9M | 0.03% | +35,732+11.8% | Added |
| Braidwell LP | 358,056 | $28.4M | 0.95% | +358,056 | New |
| Dimensional Fund Advisors LP | 389,285 | $30.8M | 0.01% | +30,448+8.5% | Added |
| Artal Group S.A. | 400,000 | $31.7M | 1.83% | −100,000−20.0% | Reduced |
| Geode Capital Management, LLC | 412,127 | $32.6M | 0.00% | +12,865+3.2% | Added |
| Hood River Capital Management LLC | 426,879 | $33.8M | 1.23% | +10,123+2.4% | Added |
| First Light Asset Management, LLC | 473,691 | $37.5M | 3.48% | −18,864−3.8% | Reduced |
| Point72 Asset Management, L.P. | 556,252 | $44.1M | 0.17% | −702,253−55.8% | Reduced |
| Pictet Asset Management SA | 625,979 | $49.6M | 0.07% | −98,223−13.6% | Reduced |
| Credit Suisse AG | 682,880 | $54.1M | 0.06% | +4,410+0.6% | Added |
| Frazier Life Sciences Management, L.P. | 999,737 | $79.2M | 4.92% | −18,651−1.8% | Reduced |
| State Street Corp | 1,038,983 | $82.3M | 0.00% | +44,839+4.5% | Added |
| Vanguard Group Inc | 1,188,110 | $94.1M | 0.00% | +91,978+8.4% | Added |
| Lord, Abbett & Co. LLC | 1,278,022 | $101.2M | 0.36% | +66,081+5.5% | Added |
| Avoro Capital Advisors LLC | 1,410,000 | $111.7M | 1.67% | +135,000+10.6% | Added |
| BlackRock Inc. | 1,699,596 | $134.6M | 0.00% | +134,291+8.6% | Added |
| Redmile Group, LLC | 1,896,645 | $150.3M | 6.15% | −2,900−0.2% | Reduced |
| FMR LLC | 2,108,853 | $167.1M | 0.02% | +2,419+0.1% | Added |
| Tudor Investment Corp Et Al | 0 | $0 | 0.00% | −11,546−100.0% | Sold out |
| Squarepoint Ops LLC | 0 | $0 | 0.00% | −8,320−100.0% | Sold out |
| Occudo Quantitative Strategies LP | 0 | $0 | 0.00% | −6,703−100.0% | Sold out |
| Schonfeld Strategic Advisors LLC | 0 | $0 | 0.00% | −5,159−100.0% | Sold out |
| Ensign Peak Advisors, Inc | 0 | $0 | 0.00% | −3,670−100.0% | Sold out |
| Amundi | 0 | $0 | 0.00% | −1,762−100.0% | Sold out |
| Almanack Investment Partners, LLC. | 0 | $0 | 0.00% | −732−100.0% | Sold out |
| Macquarie Group Ltd | 0 | $0 | 0.00% | −382−100.0% | Sold out |
| AlphaMark Advisors, LLC | 0 | $0 | 0.00% | −10−100.0% | Sold out |
| SJS Investment Consulting Inc. | 0 | $0 | 0.00% | −1−100.0% | Sold out |
| ACT Capital Management, LLC | – | – | – | – | Not filed |
| Wipfli Financial Advisors LLC, | – | – | – | – | Not filed |